MEDICATION PREFERENCES OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) PATIENTS

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-SAPS-006
• By: ARAJA, Diana (Latvia)
• Co-author(s): Diana Araja: Riga Stradins University, Riga, Latvia
  Elenka Brenna: Università Cattolica del Sacro Cuore, Rome, Italy
  Derek Pheby: Buckinghamshire New University, London, United Kingdom
  Uldis Berķis: Riga Stradins University, Riga, Latvia
  Asja Lunga: Riga Stradins University, Riga, Latvia
  Modra Murovska: Riga Stradins University, Riga, Latvia
  
• Abstract:

  Background

  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a multi-system disorder, which lead to substantial reductions in functional activity and quality of life. There are no Europe-wide prevalence data, but it is estimated that there are some two million sufferers in Europe as a whole.

  Methods

  To achieve the goal of this research,
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login